Rejuve Longevity users can monetize their health data while contributing to advancing new longevity drugs, therapies and treatments.
Decentralized longevity research network Rejuve.AI has launched Rejuve Longevity, an app designed to democratize access to longevity treatments and insights. By leveraging AI-powered analysis and a unique token-based reward system, the app allows users to track their biological age, gain personalized health insights and contribute to a global longevity research initiative.
At the core of Rejuve Longevity is its ability to analyze extensive medical and lifestyle data, providing tailored recommendations based on over 370 biomarkers, which its creators claim makes it one of the most comprehensive longevity analysis tools currently available. The app is built on Rejuve.AI’s sophisticated AI platform that synthesizes diverse scientific studies to create a holistic understanding of health risks and potential interventions.
Crucially, users of Rejuve Longevity can also securely share their health data with longevity researchers, contributing to Rejuve.AI’s decentralized science (DeSci) projects. In return, they earn RJV tokens, the platform’s cryptocurrency, which can be used to access in-app purchases such as supplements and DNA tests.
The adoption of RJV tokens not only offers Rejuve Longevity app users the opportunity to monetize their health data but also contributes to advancing the longevity sector by providing personalized data that can aid in the development of new drugs, therapies and treatments. Users can opt-in to various studies and data-sharing initiatives to help expand the breadth and accuracy of longevity research.
The system is designed to ensure that individuals not only gain valuable insights into their health but also retain control over their personal data while being fairly compensated for its contribution to research.
“While other wellbeing apps monitor one or a few aspects of a person’s health, Rejuve Longevity allows users to earn, discover trusted products and providers, and eventually combine various data types such as genetics, epigenetics and telomeres to get a truly holistic view of their health and longevity progress,” said Rejuve.AI CEO Jasmine Smith. “It also, crucially, allows individuals to take back control of, and benefit from their personal data.”
The Rejuve Longevity app integrates with various health and wellness platforms through strategic partnerships with industry leaders in supplements, wearables, DNA sequencing and epigenetics, and includes collaborations with companies such as Garmin, Travala, TruDiagnostics and AVEA. Following a beta phase with over 4,000 users, the app is now available on both Android and iOS as a free download, with premium features set to launch through a subscription model later in the year.
Supporting longevity DeSci
Part of the SingularityNET ecosystem, Rejuve.AI’s mission is to disrupt traditional biomedical research, which has long been fragmented and slow to adapt to modern technological advancements. Dr Ben Goertzel, Rejuve.AI’s Chief AI Scientist and CEO of SingularityNET, said that AI was “advancing with remarkable speed” along with the accumulation of valuable biomedical data.
“There seems little doubt that the application of advanced AI to all this data has tremendous potential to move forward the science of longevity toward deeper understanding and toward powerful therapies for extending human healthspan,” said Goertzel. “The pharmaceutical establishment is being distressingly slow at actualizing this potential. Their business models and ways of thinking are stuck in a previous era, focused on siloing data and insights in proprietary vaults and attacking one disease at a time in isolation and in a generic way, rather than approaching health in a holistic and personal fashion.”
By decentralizing research efforts and leveraging AI-driven models, Rejuve.AI aims to address these challenges and accelerate the discovery of personalized health solutions. Through crowdsourced biomedical data and advanced computational models, the organization is working toward the ambitious goal of addressing the fundamental processes of aging and extending human healthspan.
“Rejuve.AI has the modest mission of solving all this, by rolling out the world’s most advanced AI and systems biology modeling technology on decentralized networks leveraging crowdsourced biomedical data, and applying these tools to the reduction and eventual elimination of involuntary human death,” added Goertzel. “It’s a complex and intensive job but someone’s got to do it, our lives are very literally at stake!”
Central to Rejuve.AI’s ecosystem is its tokenomic model, which incorporates both the RJV tokens and specialized non-fungible tokens (NFTs) such as Data NFTs (dNFTs) and Product NFTs (pNFTs) to ensure fair and transparent compensation for users contributing to longevity research.
